Immunitas Therapeutics Alternatives & Competitors
12 companies similar to Immunitas Therapeutics — The Human Approach to Oncology
Companies similar to Immunitas Therapeutics
Sitryx
Harnessing the power of cell metabolism to develop groundbreaking disease-modifying therap...
Oxford, United Kingdom
Paratus Sciences
Translating evolutionary insights into first-in-class medicines
Boston, United States
Merus N.V.
Merus was acquired by Genmab. To see what’s new, visit Genmab.
Utrecht, The Netherlands
Curis
Working relentlessly to develop innovative and differentiated therapeutics that improve th...
Lexington, United States
Rival Readout
Competing with Immunitas Therapeutics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Oxford BioTherapeutics
Redefining the cancer-immune synapse for novel immune checkpoint mechanisms
Oxford, United Kingdom
DEM Biopharma, Inc.
Novel Target for Solid Tumors
Cambridge, United States
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of preci...
Boston, United States
Antiverse
Designing functional antibodies for the most challenging targets.
Cardiff, United Kingdom
Y-Biologics
Exploring antibodies, creating novel therapeutics
Daejeon, Korea South
About Immunitas Therapeutics
Immunitas Therapeutics, with its slogan "The Human Approach to Oncology", is revolutionizing the field of immuno-oncology therapeutics. Founded in 2019, the company leverages a unique cross-functional, single cell genomics platform to efficiently identify and validate targets while simultaneously discovering and engine...
Development of novel therapeutics, Preclinical and clinical research, Drug licensing and partnerships
Cancer patients, Patients with autoimmune diseases, Pharmaceutical companies
Immuno-oncology, Therapeutics, Single Cell Genomics, T & NK Cell Modulator, Antibody Discovery, Human Immunology, Novel Drug Targets, Biomarker Development, Antibody Engineering, Clinical Research, Oncology, Investment, Medical Research
B2B, White Label
Licensing, Product Sales
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Immunitas Therapeutics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Immunitas Therapeutics on 11 Sep 2024. The 12 companies listed here were last checked between 12 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
